SCHAUMBURG, Ill., Feb. 8 (HSMN NewsFeed) — Sagent Pharmaceuticals, Inc., a privately held specialty pharma company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control sever…
Biopharmaceuticals
Sagent Pharmaceuticals, Strides Arcolab, labetalol

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP”
Leave a Comment